{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:48:59Z","timestamp":1776869339808,"version":"3.51.2"},"reference-count":0,"publisher":"BMJ","issue":"5121","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1959,2,28]]},"DOI":"10.1136\/bmj.1.5121.549","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T02:38:39Z","timestamp":1238639919000},"page":"549-550","source":"Crossref","is-referenced-by-count":24,"title":["Trifluoperazine Dihydrochloride (\"Stelazine\") in Paranoid Schizophrenia"],"prefix":"10.1136","volume":"1","author":[{"given":"R.","family":"Macdonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. P. S.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.1.5121.549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:37:14Z","timestamp":1601062634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.1.5121.549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1959,2,28]]},"references-count":0,"journal-issue":{"issue":"5121","published-print":{"date-parts":[[1959,2,28]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.1.5121.549","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1959,2,28]]}}}